Anti-remodeling therapy to patients with chronic heart failure and metabolic syndrome
Study of anti-remodeling effectiveness of complex pharmacotherapy to patients with chronic heart failure and metabolic syndrome using perindopril, spironolactone and bisoprolol. Anti-remodeling efficacy of the combined use of the studied drugs.
Подобные документы
Constant electrocardiostimulation in occasion of atrio-ventricular blockade. Forms of atrial fibrillation and syndrome of sinus node weakness with different stimulation regimens, as well as chronic heart failure with cardioresynchronizing therapy.
статья, добавлен 29.09.2016The concept, essence, and meaning of metabolic syndrome. Diagnosis of metabolic syndrome and development of related complications. Description of classic metabolic, hormonal, and anti-inflammatory markers. Gut microbiota and microbiome metabolite levels.
статья, добавлен 13.09.2022The functional class of heart failure on the scale for assessing the clinical state before and after treatment with furosemide, torasemide. Effect of acting loop diuretics in heart failure with reduced ejection fraction patients resynchronization therapy.
статья, добавлен 20.06.2021Heart failure is one of the most prevalent and challenging medical conditions. Purpose of the study: to identify the presence of correlation between the level of galectin-3 and renal function in patients with ischemic heart failure who are hospitalized.
статья, добавлен 14.07.2016Research of reducing circulating mononuclear progenitor cells in patients. The study of serum uric acid in patients with chronic heart failure. Consideration concentration of proangiogenic mononuclear progenitor cells in chronic heart failure patients.
статья, добавлен 13.08.2016Evaluating the prognostic value of circulating osteonectin for cumulative survival in patients with ischemic chronic heart failure. Using ELISA methods for measurements of circulating level of osteonectin. Studying increased circulating osteonectin.
статья, добавлен 14.08.2016The level of growth of fibroblasts in the serum of patients with chronic kidney disease. Contribution to the remodeling of the heart and blood vessels. The relationship between FGF-23, Klotho and troponin-I in the serum of patients in the kidneys.
статья, добавлен 17.04.2018Metabolic syndrome as a cause of stroke risk in chronic cerebral ischemia. Determination of the features of changes in the structure of the vascular wall in patients with chronic cerebral ischemia, depending on the presence of metabolic syndrome.
статья, добавлен 19.02.2021Investigation of the chronic heart failure and type 2 diabetes mellitus, which are closely inter-related conditions through different pathological mechanisms. Characteristic features of the platelets abnormalities according to glycemic control status.
статья, добавлен 24.02.2016Improved myocardial contractility. Reducing end-diastolic volume. Significant improvements in functional capacity of patients with chronic heart failure and quality of life. Transplantation of stem cells of fetal origin in treatment as effective method.
статья, добавлен 24.02.2016Feature research of paracrine secretion of РВМС cells in patients with chronic heart failure (CHF) under the action of isolated from the blood plasma of healthy donors exosomes in vitro. The high novelty of research in this area, relevant the investigate.
статья, добавлен 31.08.2022Risk of development of cardiovascular pathology in patients with terminal renal failure. Study of the features of arterial hypertension, cardiovascular remodeling and plasma level of osteopontin under the influence of candesartan cilexetil therapy.
статья, добавлен 13.01.2017Reduction of circulating endothelial progenitor cells as robust biomarkers for prediction of cardiovascular outcomes. Influence of angiotensin II receptor blocker valsartan EPCs in patients with ischemic chronic heart failure, type two diabetes mellitus.
статья, добавлен 27.08.2016Diseases of the heart and blood vessels remain the main cause of mortality. This seriously affects the course of other pathological processes, - complicating diagnosis and disrupting repair processes, which reduces the effectiveness of treatment.
статья, добавлен 25.06.2024The main components of the metabolic syndrome. Determination of clinical, functional and immunological predictors of the development of pneumonia. Cytokine synthesis in response to the inflammatory process in the bronchopulmonary system of patients.
статья, добавлен 23.02.2021To detect reactive and personal anxiety, the study used a special Spielberg- Khanin scale of reactive and personal anxiety, based on which patients with chronic circulatory failure who had a high level of anxiety (more than 46 points) were identified.
статья, добавлен 31.01.2024- 17. Diabetic retinopathy and clusters of metabolic syndrome in patients with type 2 diabetes mellitus
Study of the cluster of metabolic syndrome (MS) in diabetic retinopathy (DR). Further progression of DR is statistically significantly associated with hypertension, dyslipidemia in android obesity, hypercholesterolemia, and hypertriglyceridemia.
статья, добавлен 19.02.2021 Analysis of ITGB3 gene polymorphism in patients with acute and chronic coronary syndrome. Methods for assessing the effectiveness of dual antiplatelet therapy based on the analysis of platelet response to mechanism-dependent inducers of aggregation.
статья, добавлен 03.03.2021The search for new effective methods of effective therapeutic effect in order to improve the quality and increase the life expectancy of patients with coronary heart disease. A study of a polyphenols - resveratrol for the treatment of patients with CHD.
статья, добавлен 16.06.2024The study of the correlation of metabolic syndrome and non-alcoholic fatty liver disease. Steatal changes in the liver, which can act as an initiating component of the metabolic syndrome. Communication NAFTLD with hyperlipidemia noted by many researchers.
статья, добавлен 29.04.2019The differences between metabolic syndrome (MS) with obesity with or without comorbid pathology (chronic coronary artery disease - CAD). Diagnostic features of MS with obesity without chronic CAD. Gender-specific in the endocrine changes of pathology.
статья, добавлен 10.05.2018Study of the intensity of lipid distress syndrome in patients with nonalcoholic fatty liver disease with comorbidity with obesity and chronic kidney disease, which is accompanied by dys- and hyperlipidemia with a maximum increase in blood cholesterol.
статья, добавлен 20.09.2021Investigation of the role of metabolic disorders in the formation of disease among newborns. The study showed the clinical efficacy of the drug L-carnitine in the treatment of protein deficiency. The positive effect of "Agvantar" as metabolic therapy.
статья, добавлен 27.03.2016Analysis of carbohydrate metabolism depending on the genotype of the leptin receptor gene (Arg223Gln) in patients with coronary heart disease and obesity. Causes of lipid metabolism disorders, hyperinsulinemia and decreased tissue sensitivity to insulin.
статья, добавлен 11.12.2023Analyse the available evidence on cardiovascular safety of non-steroidal anti-inflammatory drugs. Non-steroidal anti-inflammatory drugs as the cornerstone of pain management in patients with osteoarthritis and painful conditions. Myocardial infarction.
доклад, добавлен 28.03.2014